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Abstract
Background:  We consider how representations of geographic variation in prostate cancer
incidence across Southern New England, USA may be affected by selection of study area and/or
properties of the statistical analysis.
Method: A spatial scan statistic was used to monitor geographic variation among 35,167 incident
prostate cancer cases diagnosed in Massachusetts, Connecticut and Rhode Island from 1994 to
1998, in relation to the 1990 populations of men 20+ years of age living in that region. Results from
the combined-states analysis were compared to those from single-states. Impact of scanning
procedures set to examine up to 50% or no more than10% of at-risk populations also was
evaluated.
Results: With scanning set to 50%, 5 locations in the combined-states analysis were identified with
markedly distinct incidence rates. Fewer than expected cases were estimated for nearly all
Connecticut, Rhode Island and West Central Massachusetts, whereas census tracts on and around
Cape Cod, and areas of Southwestern Connecticut and adjacent to greater Boston were estimated
to have yielded more than expected incidence. Results of single-state analyses exhibited several
discrepancies from the combined-states analysis. More conservative scanning found many more
locations with varying incidence, but discrepancies between the combined- and single-state analysis
were fewer.
Conclusion: It is important to acknowledge the conditional nature of spatial analyses and carefully
consider whether a true cluster of events is identified or artifact stemming from selection of study
area size and/or scanning properties.
Background
Spatial analyses of health events can provide helpful
information that informs our understanding of the deter-
minants and control of diseases within populations. Geo-
graphic studies have discerned the non-random nature of
health hazards [1], at-risk populations [2], disease occur-
rence [3,4], progression [5], screening [6], treatment [7,8],
and end results [9,10].
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By their nature, spatial analyses of health events are zero
sum problems wherein overall rates (cases per 100,000
persons), proportions (deaths among diagnosed cases) or
case counts (birds carrying West Nile virus) applicable to
a defined study area (nation, region, state) are disaggre-
gated to measure relative differences across smaller ana-
lytic units (counties, census tracts, exact coordinates).
Changing event counts and/or underlying populations by
expanding or contracting study area size and/or modify-
ing properties of the spatial statistic can affect estimates of
spatial variation therein. Similarly, the sensitivity of the
spatial statistic to identify event clusters specific to any
given location is known to vary by changing the proximity
of that location to a study area's boundaries [11]. As such,
findings for any given spatial analysis are best considered
as conditional and modifiable as a consequence of study
area size and/or properties of statistical procedures.
Nationwide efforts to foster regional health information
networks/organizations (RHINs/RHIOs) that span tradi-
tional geo-political boundaries demand greater under-
standing of how aggregating health and population data
may affect analysis and interpretation of disease patterns.
To date, there are few opportunities to evaluate conse-
quences of study area size selection. Sharing health related
data across states or regions is uncommon, if not
restricted, in the interest of protecting individual privacy
and confidentiality of information. Moreover, inconsist-
encies across states regarding their use of geocoding refer-
ences, statistical and mapping software further limit
possibilities to pool/combine data for multi-state studies.
Hence, researchers have limited guidance as to how (and
to what extent) findings may change by modification of
the study area.
We previously described provisional qualities of spatial
analyses related to geocoding [12], choice of statistical
methods [13,14]; surveillance period [15], covariate
adjustment [16], and spatial units chosen for analysis
[17]. Here, we consider the conditional effect of study area
size on the representation of health events. The situation
is illustrated using data on prostate cancer incidence in
Southern New England, USA. The data reported here are
unusual regarding both their level of detail (census tract
for cases and population) and coverage (3 contiguous
jurisdictions – states). Discerning the potentials and pit-
falls of spatial analytic methods will facilitate the dissem-
ination of methods among researchers and practitioners
focused on health surveillance and health system evalua-
tion.
Results
Among the 35,167 geocoded records across Southern
New England, an average annual age-adjusted incidence
rate of 194.6 incident cases per 100,000 at-risk men was
observed (See Table 1). Within Connecticut, the statewide
average annual age-adjusted incidence rate of 201.7 pros-
tate cancers per 100,000 at-risk men (5.2% above the
composite rate among men outside Connecticut) was
noted. Comparable incidence rates were 182.8 for Rhode
Island (93% of the rate outside Rhode Island) and 192.6
for Massachusetts (97% of the rate outside Massachu-
setts).
Combined-states study area
Our first comparison of combined and single-state analy-
ses employs the spatial scan statistic with properties set to
evaluate rates within locations containing as much as
50% of a study area's at-risk population (1.8 million men
in the combined-states study area, 580 K within Connecti-
cut, 174 K within Rhode Island and 1.05 million within
Massachusetts). Rate variation was observed across South-
ern New England regardless of the size of the study area
(See Figure 1 and Table 2).
When data regarding Connecticut, Rhode Island and Mas-
sachusetts were examined simultaneously, 5 locations
were identified as having incidence rates likely to differ
significantly (p < 0.05) from elsewhere across the com-
bined-states study area. For most of Rhode Island, Con-
necticut and West Central Massachusetts (Area 1) the age-
adjusted average annual incidence rate was estimated to
be 91% of expectation relative to the rate among men liv-
ing elsewhere within the Southern New England region.
For a considerably more circumscribed location north of
Greater Boston (Area 4), the incidence rate was estimated
to be only 49% of the rate observed elsewhere around the
combined-states study area.
Table 1: Prostate cancer incidence (1994–1998) and population (1990) for Southern New England and single states, USA.
Reported Cases Coded Cases (%) Population at-risk1 Avg. Annual 
incidence2
Census tracts
CT-MA-RI 38,956 35,167 (90) 3,606,842 194.6 2,400
Massachusetts (MA) 22,525 20,243 (90) 2,097,746 192.6 1,331
Connecticut (CT) 12,501 11,735 (94) 1,160,925 201.7 834
Rhode Island (RI) 3,930 3,189 (81) 348,171 182.8 235
1 1990 U.S. Census of males, 20+ years old. 2 Per 100,000 at-risk persons.International Journal of Health Geographics 2006, 5:8 http://www.ij-healthgeographics.com/content/5/1/8
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By comparison, census tracts on and around Cape Cod
(Area 2) were estimated to have had an incidence rate
27% greater than other locations within the combined-
states study area. Tracts in Southwestern Connecticut
(Area 3) and those to the immediate southwest of Greater
Boston (Area 5) were observed to have rates estimated to
be 33% and 26% higher, respectively, than rates found
elsewhere within the study area.
Single-state study areas
While much consistency between the combined and sin-
gle-state analyses was evident, several important differ-
ences were evident. When considering Massachusetts by
itself, for example, 6 locations were identified with rates
that differed markedly from elsewhere around the State.
Consistent with earlier results, census tracts in the western
half of the State (Area 6) yielded an age-adjusted average
annual incidence rate 81% of that observed outside that
location. Additional locations with markedly low inci-
dence again were found along the Massachusetts borders
with Rhode Island (Area 9) and New Hampshire (Area
10).
As in the combined-states analysis, the most likely loca-
tion of elevated cancer incidence specific to Massachusetts
was found among census tracts on and around Cape Cod
(Area 7) where the incidence rate was estimated to be
1.26-times greater than expectation. Census tracts around
greater Boston (Area 8) revealed a significantly high rate
of disease (1.15-times greater than expectation) that spa-
tially encompassed considerably more area, cases and per-
sons at-risk than previously detected within Area 5.
Places of significant variation in invasive prostate cancer incidence rates (using the default scanning window of up to 50%) for  Southern New England and its constituent states, USA, 1994–1998. Figure 1
Places of significant variation in invasive prostate cancer incidence rates (using the default scanning window of up to 50%) for 
Southern New England and its constituent states, USA, 1994–1998.
1
3
5
4
2
14
15
13
12



17
16
6
7
11
8
9
10
Significant Clusters 
  Higher rates than expected
  Lower rates than expected
Combined-state analysis Massachusetts
Connecticut Rhode IslandInternational Journal of Health Geographics 2006, 5:8 http://www.ij-healthgeographics.com/content/5/1/8
Page 4 of 8
(page number not for citation purposes)
Equally noteworthy, the state-specific analysis yielded a
location north east of the city (Area 11), with a signifi-
cantly elevated incidence rate (RR = 1.20) that previously
was not identified by the combined-states analysis.
Whether this location merits specific attention for disease
control efforts depends on which study area is selected for
analysis.
Rates specific to Connecticut includes 4 locations that dif-
fered from the statewide pattern and finding based on the
combined-states study area. Census tracts of Southwestern
Connecticut (Area 12) were found, as in Area 3, to have
greater than expected incidence (RR = 1.28 in relation, this
time, to the rate elsewhere around Connecticut). Whereas
the combined-states analysis found the bulk of census
tracts across the state to have a lower than expected inci-
dence rate (Area 1), the single-state analysis identified
much of the state as having had rates that were not
remarkably different from the statewide experience. Here,
lower than expected rates were limited to at-risk persons
living around West Central Connecticut (Area 13) and the
eastern most portions of the State (Area 14). A potential
concentration of greater than expected incidence that
went unrecognized in the combined-states analysis was a
location in North Central Connecticut (Area 15) that
included more than 116,000 at-risk men to have had an
incidence rate 1.22-times greater than expectation.
The most noticeable disparity between analysis of com-
bined and single-state study areas pertained to Rhode
Island where the combined-states analysis suggested
nearly all at-risk men were at lower than expected risk of
disease. Subsequently in the single-state analysis, how-
ever, incidence rates across much of the state appear to
have been at or above the overall statewide rate of disease.
Here, only among at-risk men living within census tracts
along the State's northern border (Area 17) was it esti-
mated that prostate cancer occurred at a rate below that
(87%) of what occurred elsewhere around the Rhode
Island. In the single-state analysis, men living in South
Central census tracts situated around Narragansett Bay
(Area 16) were found to have experienced an average
annual age-adjusted incidence rate 1.39-times greater
than expectation.
Use of a more restrictive scanning setting
The problem of edge effects and selection of study area
can be overcome, to a degree, by modifying properties of
the spatial statistic. By rejecting the default SaTScan set-
tings and limiting the spatial scan procedure to include a
smaller portion of a study area's at-risk population it is
possible to reduce the likelihood that identified clusters
will reach or span single-state boundaries. To illustrate, we
compared results of combined and single-state analyses
when the size of the spatial scan was limited to include no
more than 10% of a study area's at-risk population (361 K
for the combined-states analysis, 116 K within Connecti-
cut, 35 K within Rhode Island and 210 K within Massa-
chusetts).
Predictably, limit on scanning properties yielded more
(but smaller) places of likely rate variation. Using the
Table 2: Geographic variation of prostate cancer incidence using the default (50%) scanning window according to selected study areas 
across Southern New England, USA, 1994–1998.
Study Area Location* Population at-risk Size (sq km) Cases O/E** p-value
CT, MA & RI 1 1,779,267 28,174.1 16,055 0.91 0.0001
2 200,603 13,809.5 2,729 1.27 0.0001
3 115,636 973.1 1,626 1.33 0.0001
4 31,229 36.1 127 0.49 0.0001
5 63,951 382.9 830 1.26 0.0001
Massachusetts (MA) 6 408,741 37,868.3 3,465 0.81 0.0001
7 200,603 13,809.5 2,729 1.26 0.0001
8 518,190 2,102.5 5,076 1.15 0.0001
9 29,381 497.2 114 0.45 0.0001
10 31,229 36.1 127 0.48 0.0001
11 177,096 865.7 2,194 1.20 0.0001
Connecticut (CT) 12 140,890 1,313.8 1,897 1.28 0.0001
13 353,654 2,249.7 3,144 0.86 0.0001
14 64,714 3,261.4 433 0.69 0.0001
15 116,216 713.5 1,293 1.22 0.0001
Rhode Island (RI) 16 66,477 1,794.5 721 1.39 0.0001
17 168,340 1,699.7 1,366 0.87 0.0001
* Illustrated in Figure 1. ** Risk of prostate cancer for residents of a given location, relative to the risk elsewhere around the designated study area.International Journal of Health Geographics 2006, 5:8 http://www.ij-healthgeographics.com/content/5/1/8
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default setting produced 5 significant locations for the
combined-states analysis, along with 6, 4 and 2 significant
locations for the respective single-state studies, whereas
the more restrictive scanning setting yielded 18, 13, 5 and
3 significant locations, respectively (See Figure 2 and
Table 3). High rates based on the combined-states study
are, for example, now were found on and around Cape
Cod (Area 19), communities proximate to Boston (Areas
22, 25, 29 and 35), Greater Hartford (Area 28) and South-
west Connecticut (Area 21). Lower than expected inci-
dence characterized census tracts of Western and Central
Massachusetts (Areas 20 and 30), various portions of
Connecticut (Areas 26, 32 and 33), and most of Rhode
Island.
Patterns observed in the combined-states analysis gener-
ally hold for analyses specific to Massachusetts and Con-
necticut, but as before, the story regarding Rhode Island
changes more notable depending on the study area exam-
ined. The combine-state analysis yielded evidence of a
localized area along the eastern shore of Narragansett Bay
with greater than expected incidence, while the northern
portion of the state revealed a lower than expected rate of
disease. Analysis specific to Rhode Island, however, iden-
tified a larger area presumed to have elevated disease rates,
while the remainder of the state (with exception of 2 small
pockets of low incidence) exhibited rates consistent with
the statewide pattern.
Discussion
This paper examined prostate cancer incidence in South-
ern New England, 1994–1998, in order to describe
whether and how selection of study areas and/or proper-
ties of the statistical method could affect estimates of geo-
graphic variation among health events. We found
combined- and single-state analyses to share much in
Places of significant variation in invasive prostate cancer incidence rates (using a restrictive scanning window of up to 10%) for  Southern New England and its constituent states, USA, 1994–1998 Figure 2
Places of significant variation in invasive prostate cancer incidence rates (using a restrictive scanning window of up to 10%) for 
Southern New England and its constituent states, USA, 1994–1998.
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common, but several discrepancies were noted between
approaches. Our analysis also discerned that the extent of
discrepancies between combined- and single-state analy-
ses could be reduced by modifying properties of the statis-
tical analysis; limiting the capacity to scan at-risk
population for potential disease clusters, reduced the like-
lihood that identified clusters would span area bounda-
ries.
In essence, 'artifact' resulting from study area size and
selection of scanning properties is inevitable in spatial
analysis of health events. Understanding the origins of
such 'error' is an important step in effectively utilizing
available technologies for better disease control. Data
analysts must balance a desire for specificity of location of
possible event clusters (using a restrictive scanning win-
dow) with practical considerations of needing to draw
valid generalizations about patterns across large popula-
Table 3: Geographic variation of prostate cancer incidence using of a restrictive (10%) scanning window according to selected study 
areas across Southern New England, USA, 1994–1998.
Study Area Location* Population at-
risk
Size (sq km) Cases O/E** p_value
CT, MA & RI 18 340,925 3,306.1 2763 0.79 0.0001
19 200,603 13,809.5 2729 1.27 0.0001
20 239,448 17,572.6 1917 0.77 0.0001
21 115,636 973.1 1626 1.33 0.0001
22 376,304 1,935.3 3925 1.16 0.0001
23 5,741 5.3 0 0.00 0.0001
24 31,229 36.1 127 0.49 0.0001
25 177,096 865.7 2194 1.21 0.0001
26 117,550 1,179.9 966 0.77 0.0001
27 6,027 0.4 0 0.00 0.0001
28 116,216 713.5 1293 1.24 0.0001
29 20,338 12.8 220 1.66 0.0001
30 91,701 1,626.0 774 0.82 0.0003
31 17,970 86.9 211 1.50 0.0010
32 28,139 42.5 228 0.71 0.0016
33 32,013 779.3 225 0.73 0.0118
34 19,704 28.8 159 0.69 0.0220
35 3,526 1.3 42 2.33 0.0479
Massachusetts (MA) 36 164,636 13,224.3 1325 0.73 0.0001
37 185,321 13,167.3 2546 1.27 0.0001
38 29,381 497.2 114 0.45 0.0001
39 5,741 5.3 0 0.00 0.0001
40 31,229 36.1 127 0.48 0.0001
41 177,096 865.7 2194 1.20 0.0001
42 6,027 0.4 0 0.00 0.0001
43 204,367 1,542.7 2174 1.19 0.0001
44 144,083 3,295.9 1193 0.82 0.0001
45 39,483 169.3 546 1.37 0.0001
46 20,338 12.8 220 1.64 0.0001
47 14,521 7.9 126 1.70 0.0010
48 19,704 28.8 159 0.69 0.0098
Connecticut (CT) 49 105,999 920.8 1487 1.32 0.0001
50 105,495 1,488.9 860 0.75 0.0001
51 64,714 3,261.4 433 0.69 0.0001
52 116,216 713.5 1293 1.22 0.0001
53 28,139 42.5 228 0.69 0.0002
Rhode Island (RI) 54 36,996 912.2 424 1.51 0.0001
55 31,645 31.8 215 0.71 0.0002
56 28,593 28.3 198 0.75 0.0245
* Illustrated in Figure 2. ** Risk of prostate cancer for residents of a given location, relative to the risk elsewhere around the designated study area.International Journal of Health Geographics 2006, 5:8 http://www.ij-healthgeographics.com/content/5/1/8
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tions or study areas (using a less restrictive scanning win-
dow). Studies suspecting focused clusters and those
involving limited geographic area may be suitable for
more restrictive scanning windows, whereas exploratory
analyses and those involving large geographies (regions,
nations) may find such restriction impractical (given the
likelihood of identifying a large number of clusters) or ill-
advised (given the greater potential for Type II error). The
volume and severity of edge effects produced necessarily
will vary by such decisions.
It could be that when the reference rate for pooled data
exceeded the rate of an individual state, the higher
expected rate for the expanded study area reduced the like-
lihood that particular places would exhibit rates that were
significantly higher than that new expectation, whereas
the likelihood observing places where rates were signifi-
cantly below that expectation would have been somewhat
greater. In most but not all findings reported in Tables 2
and 3, the changes in estimated ratios of observed-to-
expected incidence for specific locales were consistent
with the modification of the baseline rates from the com-
bined to the single-state study areas. Most illustrative of
were changes related to Rhode Island data.
Here, we considered geographic variation in cancer inci-
dence across three jurisdictions (states) that are distin-
guishable regarding their respective social, political,
economic, health care and environmental systems and for
which data furnished from three independent registries
that may have differed regarding definitions, techniques
and standards for reporting cancer incidence. Hopefully,
the analysis, unusual for its detail (census tract data) and
coverage (3 states), will foster greater appreciation of the
opportunities and challenges of pooling health data from
contiguous jurisdictions.
Conclusion
Fully distinguishing 'real' variation due to the geographic
distribution of risk, rather than artifact attributable to
study area, statistical procedures and/or data systems may
not be possible. How particular findings might differ by
adding/deleting adjacent areal units to a study area is not
typically considered by investigators. Consequently, spa-
tial analysis results may be rightfully considered condi-
tional upon the particular geography selected for study.
Unlike epidemiology studies of disease etiology or clinical
effect where sampling assures cases are representative of
an underlying population, geographic studies of health
events do not similarly sample locations within a 'popu-
lation' of possible places for study, but rather, rely on con-
tiguous areas often aggregated by administrative/political
reasons. Short of analyzing entire geographies, there are
no a priori ways to distinguish the appropriate size or loca-
tion of study area. Decisions typically rest on suspicion/
anecdote regarding the uniqueness of settings and/or the
availability of data for study. Hence, these findings under-
score the conditional nature of spatial analyses and call
for careful consideration before asserting 'true' clusters of
events are present.
For the future, states and similar jurisdictions must pursue
strategies that maximize potential for data to be pooled
and analyzed across conventional geopolitical bounda-
ries. Investment in geocoding, reference street files, data
systems and GIS software should commit to principles of
data sharing at the same time that procedures are imple-
mented to maintain privacy of personal and group infor-
mation.
Methods
Southern New England states of Connecticut, Massachu-
setts and Rhode Island consist of 17,644 square miles spa-
tially organized within 3 States, 27 counties, 559 towns
and 2,400 census tracts. It is home to approximately 3.6
million men 20 years of age and older. The geography of
cancer incidence during this period was examined in rela-
tion to the populations-at risk within census tracts as enu-
merated by the 1990 U.S. Decennial Census of the
Population, broken down according to ten-year age cate-
gories (i.e., 20–29 years, 30–39, 40–49, 50–59, 60–69,
70–79, 80+) [18]. Between 1994 and 1998, a total of
38,956 incident invasive prostate cancers (ICD-9-CM
code # 185) were recorded by statewide tumor registries in
Massachusetts, Connecticut and Rhode Island. For 35,167
records (90%), the census tract of residence at the time of
diagnosis was known and successfully assigned geo-
graphic coordinates for analysis; 3,789 records lacked suf-
ficient information to assign a census tract and therefore
were excluded from further analysis. The proportion of
records assigned census tract locations was substantially
greater for Connecticut (94%) and Massachusetts (90%)
than Rhode Island (81%). Excluded records typically con-
tained no, incomplete or ambiguous street addresses or
addresses that cited P.O. Boxes in place of street addresses.
Reason for differences across states was not readily dis-
cerned. Previous work suggests that failure to geocode
cancer events somewhat under-represented cases among
urban dwellers [12].
Based on records available for study, variation in average
annual age-adjusted incidence rates across census tracts
was evaluated using a spatial scan statistic [19]. The pro-
cedure utilizes a large number of scanning circles (>100 K)
of varying size and location to search for places (1 or more
census tracts independent of conventional geo-political
boundaries) where the number of observed cases deviated
from a null hypothesis that incidence was proportional to
population density (random). Age-adjusted case countsInternational Journal of Health Geographics 2006, 5:8 http://www.ij-healthgeographics.com/content/5/1/8
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and disease rates within and outside particular circles were
determined by SaTScan 5.1 software [20].
The spatial scan statistic is well suited for disease surveil-
lance, as it does not require a priori assumptions about
the number, place or size of locations or direction of effect
that may be identified. It takes into account the uneven
geographic distribution of the population at risk and, as
required, accounts for any number of possible confound-
ing variables. The significance of identified clusters is eval-
uated using Monte Carlo procedures, with adjusted p-
values for multiple testing, to designate locations (clusters
of census tracts) where incidence varied from the null.
Results of the spatial scan statistic are considered to be
conservative estimates of the likelihood of observing
events within given locations, relative to places elsewhere
around the study area [21].
Spatial analyses of prostate cancer incidence were com-
pleted for the 3 state study area of Southern New England,
along with analyses specific to Connecticut, Rhode Island
or Massachusetts. Findings of significantly high or low
concentrations of incident cases are reported in Tables 2
and 3 and illustrated, using Maptitude® software [22], in
Figures 1 and 2.
Competing interests
The authors have not received reimbursements, fees,
funding or salary from an organization that may in any
way gain or lose financially from the publication of this
manuscript, nor do they hold stocks or shares in an organ-
ization or other competing financial interests that may in
any way gain or lose financially from the publication of
this manuscript
Authors' contributions
D Gregorio conceived of the study and supervised all
aspects of its implementation. H Samociuk and L
DeChello assisted with the study and completed the anal-
yses. H Swede assisted in interpretation of findings and
manuscript preparation.
Acknowledgements
This publication/project was made possible through a Cooperative Agree-
ment between the Centers for Disease Control and Prevention (CDC) and 
the Association of Teachers of Preventive Medicine (ATPM), award number 
U50/CCU300860 project number TS-0431; its contents are the responsi-
bility of the authors and do not necessarily reflect the official views of the 
CDC or ATPM.
References
1. Colwell R: Infectious disease and environment: Cholera as a
paradigm for waterborne disease.  International  Microbiology
2004, 7:285-289.
2. Iceland J, Weinberg DH, Steinmetz E: U.S. Census Bureau, Series
CENSR-3,  Racial and Ethnic Residential Segregation in the
United States: 1980–2000.  Washington, DC: U.S. Government
Printing Office; 2002. 
3. Chaput EK, Meek J, Heimer R: Spatial analysis of human granu-
locytic ehrlichiosis near Lyme Connecticut.  Emerging Infectious
Diseases 2002, 8:943-948.
4. Klassen AC, Kulldorff M, Curriero F: Geographical clustering of
prostate cancer grade and stage at diagnosis, before and
after adjustment for risk factors.  International Journal of Health
Geographics 2005, 4:1.
5. Rushton G, Peleg I, Banerjee A, Smith G, West M: Analyzing geo-
graphic patterns of disease incidence: rates of late stage
colorectal cancer in Iowa.  Journal of Medical Systems 2004,
28:223-236.
6. Legler J, Breen N, Meissner H, Malec D, Coyne C: Predicting pat-
terns of mammography use: A geographic perspective on
national needs for intervention research.  Health Services
Research 2002, 37:929-947.
7. Gregorio DI, Kulldorff M, Barry L, Samociuk H, Zarfos K: Geograph-
ical differences in primary therapy for early-stage breast can-
cer.  Annals of Surgical Oncology 2001, 8:844-849.
8. Jack RH, Gulliford MC, Ferguson J, Moller H: Geographic inequal-
ities in lung cancer management and survival in South East
England: evidence of variation in access to oncology services?
British Journal of Cancer 2003, 88:1025-1031.
9. Kulldorff M, Feuer EJ, Miller BA, Freedman LS: Breast cancer clus-
ters in the Northeast United States: A geographic analysis.
American Journal of Epidemiology 1997, 146:1616-1620.
10. Lanska DJ, Kuller LH: The geography of stroke mortality in the
United States and the concept of a stroke belt.  Stroke 1995,
26:1145-1149.
11. Monmonier M: How to lie with Maps.  2nd edition. Chicago: Uni-
versity of Chicago Press; 1996. 
12. Gregorio DI, Cromley E, Tate JP, Mrozinski R, Walsh SJ, Flannery J:
Subject loss in spatial analysis of breast cancer.  Health and
Place 1997, 5:173-177.
13. Kulldorff M, Song C, Gregorio DI, Samociuk H, DeChello L: Cancer
map patterns: Are they random or not?  American Journal of Pre-
ventive Medicine (Forthcoming, 2006) .
14. Fang Z, Kulldorff M, Gregorio DI: Brain Cancer in the United
States, 1986–95: A geographic analysis.  Neuro-Oncology 2004,
6:78-82.
15. Gregorio DI, Kulldorff M, Sheehan TJ, Samociuk H: Geographic dis-
tribution of prostate cancer incidence in the era of PSA test-
ing.  Urology 2004, 63:78-82.
16. Sheehan TJ, DeChello L, Kulldorff M, Gregorio DI, Gershman S,
Mroszczyk R: The geographic distribution of breast cancer
incidence in Massachusetts 1988 to 1997, adjusted for covari-
ates.  International Journal of Health Geographics 2004, 3:17-28.
17. Gregorio DI, DeChello L, Samociuk H, Kulldorff M: Lumping or
splitting: Can a standard areal unit for health geography
studies be selected?  International Journal of Health Geographics 2005,
4:6-15.
18. Census of Population and Housing (1990)  [United States]: Sum-
mary Tape File 1, Connecticut  [http://www.census.gov].
19. Kulldorff M: A spatial scan statistic.  Communications in Statistics:
Theory and Methods 1997, 26:1481-1496.
20. Kulldorff M, Information Management Services, Inc: SaTScan™ v.
5.1: Software for the spatial and space-time scan statistics.
[http://www.satscan.org]. (12/30/2004)
21. Breslow NE, Day NE: Statistical Methods in Cancer Research,
Volume II – The Design and Analysis of Cohort Studies.  Lyon:
International Agency for Research on Cancer; 1987. 
22. Caliper Corporation: Maptitude Geographic Information Sys-
tem for Windows. Version 4.5.  Newton, MA 2001.